Moneycontrol
Oct 13, 2017 05:43 PM IST | Source: Moneycontrol.com

Cipla Q2 PAT seen up 13% YoY to Rs. 406 cr: Kotak

Net Sales are expected to increase by 6.7 percent Y-o-Y (up 13.5 percent Q-o-Q) to Rs. 4001 crore, according to Kotak.

Cipla Q2 PAT seen up 13% YoY to Rs. 406 cr: Kotak

Kotak has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Cipla to report net profit at Rs. 406 crore up 13% year-on-year (down 4.5% quarter-on-quarter).


Net Sales are expected to increase by 6.7 percent Y-o-Y (up 13.5 percent Q-o-Q) to Rs. 4001 crore, according to Kotak.


Earnings before interest, tax, depreciation and amortization (EBITDA) are likely to rise by 5.3 percent Y-o-Y (up 11.3 percent Q-o-Q) to Rs. 719.5 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

X
Sections
Follow us on
Available On